bpc-157 synthetic gastric pentadecapeptide Stable BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System BPC-157 Peptide (Pentadecapeptide) 5mg, 10mg

doi: 10.1038/nature14893

Inflammatory Bowel Disease (IBD) and Colitis In models of ulcerative colitis and Crohns-like inflammation, BPC-157 reduced symptoms such as: Intestinal bleeding Epithelial erosion Immune cell infiltration Weight loss and diarrhea BPC-157 therapy improved outcomes in acetic acid-induced colitis models, reducing oxidative stress and promoting mucosal regeneration. Tkalcevic, V

These options are supported by extensive research, clinical experience, and regulatory frameworks designed to ensure patient safety and therapeutic efficacy

And so there are peptides that you can use to enhance your bodys ability to produce what it physiologically can